Major Neuroscience Initiative Launched
Spearheaded by a $115 million gift from visionary philanthropists Tianqiao Chen and Chrissy Luo, Caltech and the Tianqiao and Chrissy Chen Institute are announcing the launch of a campus-wide neuroscience initiative to create a unique environment for interdisciplinary brain research. The goal of the new endeavor is to deepen our understanding of the brain — the most powerful biological and chemical computing machine — and how it works at the most basic level as well as how it fails because of disease or through the aging process.
Central to the initiative is the creation of the Tianqiao and Chrissy Chen Institute for Neuroscience at Caltech, where research investigations will span a continuum, from deciphering the basic biology of the brain to understanding sensation, perception, cognition, and human behavior, with the goal of making transformational advances that will inform new scientific tools and medical treatments.
The Tianqiao and Chrissy Chen Institute at Caltech will be supported through the Chens' investment, which includes endowed funds to be used at the discretion of Caltech's leadership to support activities such as seeding new lines of research and supporting promising early-career faculty and scholars. In addition, as part of the neuroscience initiative, Caltech will construct a $200 million biosciences complex named in honor of the Chens that will include state-of-the-art facilities for the Chen Institute at Caltech.
Involving faculty from across the university's six academic divisions, the Chen Institute at Caltech will catalyze a campus-wide interdisciplinary community of neuroscientists, biologists, chemists, physicists, engineers, computer scientists, and social scientists, all with the shared goal of understanding the fundamental principles that underlie brain function. The new building will be a nexus for neuroscience research on campus. It will comprise shared lab spaces and centralized areas that foster interaction and collaboration, amplifying and extending Caltech's long traditions in molecular, cellular, and systems neuroscience. As part of the commitment to the partnership, Caltech will also co-invest significant resources to be deployed for the Chen Institute at Caltech's operations.
"It is a privilege to launch this vital collaborative effort with Tianqiao Chen and Chrissy Luo," says Caltech president Thomas Rosenbaum, the Sonja and William Davidow Presidential Chair and professor of physics. "We share a vision with our cornerstone partners, the Chens, of translating insights into the fundamental biology, chemistry, and physics of the brain into a deeper understanding of how human beings perceive and interact with the world, and how technological interventions can improve the human experience."
"Our involvement in the Internet and entertainment industries allowed us to witness the ability for technology advancements to influence human perception, as well as to observe the resultant meaningful effects on human behavior," says Tianqiao Chen, co-founder of the Tianqiao and Chrissy Chen Institute. "However, there is little understanding about how the brain processes and connects what lies in between — sensation, perception, cognition, and action. We believe uncovering how the brain perceives, interprets, and interacts with the world is pivotal in so many aspects. It can shape groundbreaking industries such as artificial intelligence, robotics, and virtual reality. It also plays a critical role in addressing social issues such as aging and behavioral deficiencies. It can even help answer many ultimate questions about life, such as its origin, purpose, and ending. This is the mission of our philanthropy, and we are dedicating an initial one billion dollars to this cause."
Chrissy Luo, co-founder of Shanda and the Tianqiao and Chrissy Chen Institute, adds, "We spent two years learning the subject from highly regarded global universities with whom we continue to have conversations. We chose Caltech as our first partner not just for their strong reputation as a leading research institution, but also for the admiration in their natural alignment with Shanda's culture, which is focused on creating excellence and discovery. We have enjoyed the strong working relationship with Caltech and are firmly confident of this partnership."
David J. Anderson, the Seymour Benzer Professor of Biology and a Howard Hughes Medical Institute Investigator, will serve as the director of the new neuroscience institute, which will comprise five interdisciplinary research centers—including four new centers, founded through the gift from the Chens, and one existing center. Anderson will be named the inaugural holder of the Tianqiao and Chrissy Chen Institute for Neuroscience Leadership Chair.
"Modern neuroscience is one of the most interdisciplinary fields of human intellectual endeavor in the 21st century, and no single researcher or laboratory can master all of the diverse approaches necessary to solve the challenging problems of brain structure, function, and dysfunction," Anderson says. "The Chen Institute at Caltech provides an unprecedented opportunity for Caltech faculty and students in different fields to join forces to take on these challenges, by creating new collaborations at the interface between traditional scientific disciplines. Computational approaches—grounded in Caltech's traditional strength in the physical sciences—will provide a common glue that binds these collaborations together."
Adds Anderson, "Caltech's traditional strengths in basic biology and the physical sciences provide an ideal crucible in which to forge new tools that will crack the most fundamental problems of brain function, such as perception, emotion, cognition, and communication, as well as to develop radical new therapies for currently intractable brain disorders."
Story from California Institute of Technology. Original piece written by Kathy Svitil. Please note: The content above may have been edited to ensure it is in keeping with Technology Networks’ style and length guidelines.
Combination Chemotherapy Could Significantly Improve Deadly Brain Tumor TreatmentNews
A team led by Massachusetts General Hospital (MGH) investigators has found that adding the chemotherapy drug hydroxyurea to the current chemotherapy protocol for glioblastoma significantly increased survival in animal models.READ MORE
Purine Synthesis in Neuron-Like Cells InvestigatedNews
Neuron-like cells created from a readily available cell line have allowed researchers to investigate how the human brain makes a metabolic building block essential for the survival of all living organisms.READ MORE
All in a Droplet: Atomic Resolution of ALS Protein ResolvedNews
Researchers have described atom-by-atom changes in a family of proteins linked to amyotrophic lateral sclerosis (ALS), a group of brain disorders known as frontotemporal dementia and degenerative diseases of muscle and bone.READ MORE